Lilly Granted Priority Review For Headache Treatment

Posted: Updated:
The drug received FDA approval for migraine treatment in September. The drug received FDA approval for migraine treatment in September.
INDIANAPOLIS -

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says one of its headache treatments is moving closer to approval. The U.S. Food and Drug Administration has granted Priority Review for a drug to be used for the preventative treatment of episodic cluster headache in adults.

Lilly says if its supplemental Biologics License Application for the drug Emgality is approved, it could potentially represent a significant advancement in treatment for a serious condition. Emgality is an injection treatment that received FDA approval in September to treat migraine in adults.

Emgality also received Breakthrough Therapy Designation from the FDA in September for the treatment of episodic cluster headache. The pharmaceutical giant says episodic cluster headache is a disabling disorder that affects about 124 per 100,000 adults.

"Cluster headache is a severely disabling and excruciatingly painful neurological disorder. Few treatment options are available, and only a limited body of research from rigorous clinical trials exists," said Gudarz Davar, vice president of neurology development at Lilly Bio-Medicines. "We are pleased the FDA has granted Priority Review for our sBLA, acknowledging the need for new treatments for this devastating disease and bringing us closer to potentially offering a preventive treatment option for these patients."

Lilly says it is currently recruiting for Phase 3 studies to evaluate Emgality for the prevention of migraine in children and adolescents, aged six to 17.

  • Perspectives

    • Ahh…Yes! Turning a Hot Mess into a Cool Breeze

      "Problems cannot be solved by the level of thinking that created them," is attributed to Einstein over 75 years ago. This still holds true, particularly in challenging communications. Many people address conflict at the level it was created by rehashing and building more evidence for their ‘side’ of an argument. Repeating a position tends to intensify the separation of people.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Aasif Bade (pictured left) is president and Patrick Chittenden (pictured right) is executive vice president of Ambrose Property Group.

      Waterside Developer: City Has 'Violated Our Rights'

      The chief executive officer of Indianapolis-based Ambrose Property Group says the firm is preparing for litigation regarding the future of the former GM Stamping Plant site. In a response to a letter from the city of Indianapolis this week, Aasif Bade says the city's continued threat of acquiring the site of the $1.4 billion Waterside redevelopment project through eminent domain "has violated our rights and is harming the community by putting Waterside in a state...

    • Purdue Global Now Offers Analytics Degree

      The U.S. Bureau of Labor Statistics reports that jobs in the field of data analysis are projected to grow 26 percent over the next ten years. Acting upon that data, Indianapolis-based Purdue University Global has launched a new Bachelor of Science degree program in analytics. 

    • Bob Stutz

      New Role For Salesforce Exec

      After three years on the job, Salesforce Marketing Cloud Chief Executive Officer Bob Stutz is moving into a new role. Stutz, who will remain in Indianapolis, is now executive vice president of strategic partners at Salesforce (NYSE: CRM).  Since arriving in Indianapolis, Stutz has overseen the establishment of the company’s regional headquarters in downtown Indianapolis, which included the Salesforce name being placed atop the state’s tallest building.

    • Red Star announced plans to expand and add 18 jobs.

      Larwill Medical Device Maker to Expand, Add Jobs

      A Whitley County-based medical device maker has announced plans to expand its facility in Larwill which should mean new jobs. Red Star Contract Manufacturing Inc. says it will invest $1.6 million in real estate improvements and additional equipment and will create 18 new jobs by 2022. 

    • (photo courtesy of the Center for the Performing Arts)

      Center for the Performing Arts Launches Naming Campaign

      The Center for the Performing Arts in Carmel is looking for its first-ever corporate naming partner. The nonprofit, which is approaching its 10th anniversary, says it hopes to find a partner with a “shared vision of advancing the arts and educational programming, unifying the community and extending the center’s impact.” The campaign to find a partner follows a strategic planning process, which involved an independent analysis from Chicago-based sponsorship...